572 related articles for article (PubMed ID: 30984194)
1. Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During
Ambrosio LF; Insfran C; Volpini X; Acosta Rodriguez E; Serra HM; Quintana FJ; Cervi L; Motrán CC
Front Immunol; 2019; 10():631. PubMed ID: 30984194
[TBL] [Abstract][Full Text] [Related]
2. Limited Foxp3
Araujo Furlan CL; Tosello Boari J; Rodriguez C; Canale FP; Fiocca Vernengo F; Boccardo S; Beccaria CG; Adoue V; Joffre O; Gruppi A; Montes CL; Acosta Rodriguez EV
Front Immunol; 2018; 9():2555. PubMed ID: 30455700
[TBL] [Abstract][Full Text] [Related]
3. Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3(+) T cells.
González FB; Villar SR; Fernández Bussy R; Martin GH; Pérol L; Manarin R; Spinelli SV; Pilon C; Cohen JL; Bottasso OA; Piaggio E; Pérez AR
Brain Behav Immun; 2015 Mar; 45():219-32. PubMed ID: 25483139
[TBL] [Abstract][Full Text] [Related]
4. Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4+CD25+Foxp3+ regulatory T cells.
Schulz VJ; Smit JJ; Bol-Schoenmakers M; van Duursen MB; van den Berg M; Pieters RH
Toxicol Lett; 2012 Nov; 215(2):100-9. PubMed ID: 23041608
[TBL] [Abstract][Full Text] [Related]
5. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
Kotner J; Tarleton R
Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
[TBL] [Abstract][Full Text] [Related]
6. CD39 expression by regulatory T cells participates in CD8+ T cell suppression during experimental Trypanosoma cruzi infection.
Araujo Furlan CL; Boccardo S; Rodriguez C; Mary VS; Gimenez CMS; Robson SC; Gruppi A; Montes CL; Acosta Rodríguez EV
PLoS Pathog; 2024 Apr; 20(4):e1012191. PubMed ID: 38683845
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms.
Poncini CV; Ilarregui JM; Batalla EI; Engels S; Cerliani JP; Cucher MA; van Kooyk Y; González-Cappa SM; Rabinovich GA
J Immunol; 2015 Oct; 195(7):3311-24. PubMed ID: 26324777
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.
Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST
Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388
[TBL] [Abstract][Full Text] [Related]
9. P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.
Dhiman M; Garg NJ
PLoS Pathog; 2014 Dec; 10(12):e1004516. PubMed ID: 25474113
[TBL] [Abstract][Full Text] [Related]
10. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
11. AhR Ligands Modulate the Differentiation of Innate Lymphoid Cells and T Helper Cell Subsets That Control the Severity of a Pulmonary Fungal Infection.
de Araújo EF; Loures FV; Preite NW; Feriotti C; Galdino NA; Costa TA; Calich VLG
Front Immunol; 2021; 12():630938. PubMed ID: 33936043
[TBL] [Abstract][Full Text] [Related]
12. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
13.
Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
Front Immunol; 2019; 10():1456. PubMed ID: 31293599
[No Abstract] [Full Text] [Related]
14. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection.
Mariano FS; Gutierrez FR; Pavanelli WR; Milanezi CM; Cavassani KA; Moreira AP; Ferreira BR; Cunha FQ; Cardoso CR; Silva JS
Microbes Infect; 2008 Jun; 10(7):825-33. PubMed ID: 18538611
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation of alloreactive CD8+ T cells toward a regulatory T cell phenotype by a mechanism that is dependent on aryl hydrocarbon receptor in CD4+ T cells.
Funatake CJ; Marshall NB; Kerkvliet NI
J Immunotoxicol; 2008 Jan; 5(1):81-91. PubMed ID: 18382861
[TBL] [Abstract][Full Text] [Related]
16. The Aryl Hydrocarbon Receptor Modulates Production of Cytokines and Reactive Oxygen Species and Development of Myocarditis during Trypanosoma cruzi Infection.
Barroso A; Gualdrón-López M; Esper L; Brant F; Araújo RR; Carneiro MB; Ávila TV; Souza DG; Vieira LQ; Rachid MA; Tanowitz HB; Teixeira MM; Machado FS
Infect Immun; 2016 Oct; 84(10):3071-82. PubMed ID: 27481250
[TBL] [Abstract][Full Text] [Related]
17. IL-10 participates in the expansion and functional activation of CD8
Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
[TBL] [Abstract][Full Text] [Related]
18. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
[TBL] [Abstract][Full Text] [Related]
19. AhR activation increases IL-2 production by alloreactive CD4
Ehrlich AK; Pennington JM; Tilton S; Wang X; Marshall NB; Rohlman D; Funatake C; Punj S; O'Donnell E; Yu Z; Kolluri SK; Kerkvliet NI
Eur J Immunol; 2017 Nov; 47(11):1989-2001. PubMed ID: 28833046
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection.
Martin DL; Postan M; Lucas P; Gress R; Tarleton RL
Eur J Immunol; 2007 Oct; 37(10):2764-71. PubMed ID: 17823982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
